Cerebral Microbleeds are Common in Ischemic Stroke But Rare in TIA
Neurol 65:1914-1918, Werring,D.J.,et al, 2005
Hyponatremia from Oxcarbazepine and Carbamazepine
Neurol 65:1976-1978, Dong,X.,et al, 2005
Hemostatic Treatment in the Early Stage of Intracerebral Hemorrhage, The Recombinant Factor VIIa Experience
Stroke 36:2321-2322, Kase,C.S., 2005
Sickle Cell Trait is a Risk Factor for Early Stroke
Arch Neurol 62:1778-1779,1781, Golomb,M.R., 2005
Sickle Cell Trait Is Not a Risk Factor for Stroke
Arch Neurol 62:1780-1781, Dowling, M.M., 2005
Guillain-Barre Syndrome
Lancet 366:1653-1666, Hughes,R.C. &Comblath,D.R., 2005
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death
NEJM 353:2034-2041, Yaggi,H.K.,et al, 2005
Occupation and Parkinsonism in Three Movement Disorders Clinics
Neurol 65:1430-1435, Goldman,S.M.,et al, 2005
Excessive Daytime Sleepiness and Subsequent Development of Parkinson Disease
Neurol 65:1442-1446, Abbott,R.D.,et al, 2005
Neurological and Neuromuscular Disease as a Risk Factor for Respiratory Failure in Children Hospitalized With Influenza Infection
JAMA 294:2188-2194, Keren,R.,et al, 2005
Efficacy of TNF a Blockade in Cyclophosphamide Resistant Neuro-Behet Disease
JNNP 76:1733-1735, Ribi,C.,et al, 2005
Neurologic and Developmental Disability at Six Years of Age After Extremely Preterm Birth
NEJM 352:9-19, 71, Marlow,N.,et al, 2005
Clinical and Imaging Predictors of Intracerebral Haemorrhage in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
JNNP 76:70-75, Derex,I.,et al, 2005
Prognostic Significance of Admission Levels of Troponin I in Patients With Acute Ischaemic Stroke
JNNP 76:76-81, Di Angelantonio,E.,et al, 2005
Identification, Prognosis, and Management of Patients with Carotid Artery Near Occlusion
AJNR 26:2086-2094, Fox,A.J.,et al, 2005
NT-3 Promotes Nerve Regeneration and Sensory Improvement in CMT1A Mouse Models and in Patients
Neurol 65:681-689, 662, Sahenk,Z.,et al, 2005
Use of Complementary and Alternative Therapies in Epilepsy, Cause for Concern
Arch Neurol 62:1472-1475, Pearl,P.L.,et al, 2005
Recent Use of Oral Contraceptives and the Risk of Multiple Sclerosis
Arch Neurol 62:1362-1365, Alonso,A.,et al, 2005
Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke
Stroke 36:1115-1119, Marini,C.,et al, 2005
Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke
Stroke 36:1316-1329, Di Napoli,M.,et al, 2005
Early Carotid Atherosclerosis in Subjects With Periodontal Diseases
Stroke 36:1195-1200, Soder,P-O.,et al, 2005
Clinical Importance of Microbleeds in Patients Receiving IV Thrombolysis
Neurol 65:1175-1178, Kakuda,W.,et al, 2005
Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia, Meta-analysis of Randomized Placebo-Controlled Trials
JAMA 294:1934-1943,1963, Schneider,L.S.,et al, 2005
Bone Mineral Density and the Risk of Alzheimer Disease
Arch Neurol 62:107-111, Tan,Z.S.,et al, 2005
A 32-Year Prospective Study of Change in Body Weight and Incident Dementia
Arch Neurol 62:55-60,20, Stewart,R.,et al, 2005
Risk Factors for Stroke in Subjects With Normal Blood Pressure
Stroke 36:234-238, Li,C., et al, 2005
Outdoor Air Pollution and Stroke in Sheffield, United Kingdom
Stroke 36:239-243, Maheswaran, R., et al, 2005
Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila in Elderly Patients With Stroke (C-PEPS, M-PEPS, L-PEPS)
Stroke 36:259-263, Ngeh, J. & Goodbourn, C., 2005
Vascular Risk Factors and Diabetic Neuropathy
NEJM 352: 341-350, 408, Tesfaye, S., et al, 2005
A Fatal Encephalitis
Lancet 365:358, Schankin, C.J., et al, 2005
Phenytoin Exposure Is Associated With Functional and Cognitive Disability After Subarachnoid Hemorrhage
Stroke 36:583-587, Naidech,A., et al, 2005
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
NEJM 352: 777-785, 828, Mayer, S.A., et al, 2005
Risk of Ischaemic Stroke in People With Migraine: Systemic Review and Meta-analysis of Observational Studies
BMJ 330:63-65, 54, Etminan,M.,et al, 2005
Homocysteine and Stroke: Evidence on a Causal Link From Mendelian Randomisation
Lancet 365:224-232, 194, Casas, J.P., et al, 2005
Association Between Hormone Replacement Therapy and Subsequent Stroke: A Meta-analysis
BMJ 330:342-345, Bath, P.M.W. & Gray, L.J., 2005
Timing of TIAs Preceding Stroke
Neurol 64:817-820, Rothwell, P.M. & Warlow, C.P., 2005
Atypical Antipsychotic Drugs and Risk of Ischaemic Stroke: Population Based Retrospective Cohort Study
BMJ 330:445-448, Gill,S.S., et al, 2005
Lamotrigine and the Risk of Malformations in Pregnancy
Neurol 64:955-960, 938, Cunnington, M. , et al, 2005
Recurrent Stroke Associated with Cannabis Use
JNNP 76:435-437, Mateo,I.,et al, 2005
Blood Pressure Control and Risk of Stroke
Stroke 36:725-730, Li,C.,et al, 2005
Ximelagatran vs Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
JAMA 293:690-698,736, SPORTIF Executive Steering Committee for the SPORTIF V Investigators, 2005
Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation
JAMA 293:699-706, OBrien,C.L. &Gage,B.F., 2005
Maternal and Infant Characteristics Associated with Perinatal Arterial Stroke in the Infant
JAMA 293:723-729, Lee,J.,et al, 2005
Ximelagatran--Promises and Concerns
JAMA 293:736-739, Gurewich,V., 2005
Role of Cerebral Amyloid Angiopathy in Intracerebral Hemorrhage in Hypertensive Patients
Neurol 64:1233-1237, Ritter,M.A.,et al, 2005
Cellular Telephones and Risk for Brain Tumors
Neurol 64:1189-1195, Christensen,H.C.,et al, 2005
Adding Aspirin to Clopidogrel After TIA and Ischemic Stroke
Neurol 64:1117-1121, Hankey,G.J. &Eikelboom,J.W., 2005
Gadolinium Encephalopathy in a Patient with Renal Failure
Neurol 64:1276-1278, Maramattom,B.V.,et al, 2005
Neuropathy Resembling CIDP in Patients Receiving Tumor Necrosis Factor-a Blockers
Neurol 64:1468-1470, Richez,C.,et al, 2005
Reversal of Warfarin-Induced Anticoagulation with Factor VIIa Prior to rt-PA in Acute Stroke
Neurol 64:1480-1481, Talkad,A.,et al, 2005